Nanotech Investing Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel , an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies
Nanotech Investing Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
Nanotech Investing Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma
Nanotech Investing Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference
Nanotech Investing Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update
RZOLV Technologies Appoints Mary Ellen Thorburn to the Board of Directors; Announces the Retirement of Darryl Yea
Homerun Resources Inc. Announces Positive Results of Confirmation Testing by Minerali Industriali Engineering on the Santa Maria Eterna Silica Sand for the Manufacture of Antimony-Free Solar Glass
HyProMag USA Finalizes Long Term Lease for Dallas-Fort Worth Rare Earth Magnet Recycling and Manufacturing Hub
